$PHAT 3 SEC Filings

Filed On	Filing
07 Oct 2025	Form 3: Narula Sanjeev, Chief Financial & Bus. Officer Holds 0 shares of No securities are beneficially owned.
24 Jun 2025	Form 3: Cook Anne Marie, Chief Legal Off. & Corp. Sec. Holds 0 shares of No securities are beneficially owned.
06 May 2025	Form 3: Breedlove Robert Charles, Principal Accounting Officer Holds 50,084 shares of Common Stock
16 Apr 2025	Form 3: Schroeder Theodore R, Director Holds 0 shares of No securities are beneficially owned.
03 Apr 2025	Form 3: Basta Steven L, Director Holds 0 shares of No securities are beneficially owned.
26 Jan 2024	Form 3: Medicxi Ventures Management (Jersey) Ltd, 10% owner and 6 others Holds 3,673,602 shares of Common Stock
26 Apr 2022	Form 3: Karbe Frank, Director No securities owned
06 Apr 2022	Form 3: Henderson Molly, CFO and CBO No securities owned
11 Jun 2021	Form 3: Guzzo Anthony J., VP, Chief Accounting Officer Holds 804 shares of Common Stock
13 Jul 2020	Form 3: Branning Todd P., Chief Financial Officer No securities owned
19 Mar 2020	Form 3: Stenhouse Mark, Director No securities owned
12 Dec 2019	Form 3: Parikh Asit, Director No securities owned
04 Nov 2019	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Holds 3,646,646 shares of Common Stock
24 Oct 2019	Form 3: Frazier Life Sciences IX, L.p., 10% owner and 4 others Holds 4,877,998 shares of Common Stock
24 Oct 2019	Form 3: Yamada Tadataka, Director Holds 1,686,704 shares of Common Stock
24 Oct 2019	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner Holds 1,084,000 shares of Common Stock
24 Oct 2019	Form 3: Socks David A, Director Holds 1,686,704 shares of Common Stock
24 Oct 2019	Form 3: Slavinsky Christopher W., Director No securities owned
24 Oct 2019	Form 3: Nabulsi Azmi, Chief Operating Officer Holds 867,200 shares of Common Stock
24 Oct 2019	Form 3: Kohli Aditya, Chief Business Officer Holds 843,352 shares of Common Stock

Comments